AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05095974 — intervention group
Intervention type: DEVICE
Intervention: thoracic electrical bioimpedence
Description: EC ICONR monitor (Osypka Medical, Inc., La Jolla, California and Berlin) will be applied to the patients through four ECG electrodes. The electrodes will be placed over the bare skin of patients at the following sites: (1) on the left neck below the ear; (2) directly superior to the midpoint of the left clavicle; (3) along the left mid-axillary line at the level of the xiphoid process; (4) two-inches caudad from the third electrode.
Study NCT06800560 — intervention group
Intervention type: OTHER
Intervention: PREDICT-FFQ-v1
Description: Food frequency questionnaire
Study NCT06801665 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: FMT+QL1706+Bevacizumab+XELOX
Description: Participants will receive FMT combined with QL1706+Bevacizumab+XELOX for 6 cycles. If there is no progression of the disease after 6 cycles of the first-line treatment, then patients will enter the maintenance treatment stage. The therapy of maintenance treatment stage was at the discretion of the investigator.
Study NCT06800365 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensor
Description: The FreeStyle Libre Pro sensor is a device whereby a sensor is inserted into subcutaneous tissue (upper arm) and measures the interstitial blood glucose which is then available for later download. It comes pre-calibrated meaning that no fingerstick glucose monitoring is required to improve accuracy of the sensor.
Study NCT06801431 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal cord stimulation
Description: Individuals will receive a 10-day course of daily, 30-minute sessions of transcutaneous spinal cord stimulation to the thoracolumbar spine cord using the Chattanooga Mobile 2 Stim Device. These sessions will be conducted in the morning before bowel care and therapy. Cathode pads will be placed between the T10 and T11 spinous processes and the T12 and L1 spinous processes. Anode pads will be placed over the iliac crests. Stimulation will consist of 1 millisecond duration, biphasic pulses, at 30 Hertz frequency. The intensity of the current, will be adjusted to be suprasensory and sub-motor, and no more than 140 milli-amperes.
Study NCT05582018 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioTraceIO 360
Description: Use of the device for planning, monitoring and assessment of liver tissue ablations
Study NCT05044819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Oral Cannabidiol solution 100 mg/mL
Study NCT05786131 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Culprit-lesion revascularization
Description: Percutaneous coronary intervention of culprit-lesion
Study NCT05786131 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-culprit-lesion revascularization
Description: Complete percutaneous coronary intervention of all angiographically significant non-culprit lesions
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anitocabtagene Autoleucel
Description: A single infusion of CAR+ transduced autologous T cells
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Administered intravenously
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Administered intravenously
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pomalidomide
Description: Tablet administered orally
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bortezomib
Description: Administered intravenously or subcutaneously
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Tablet administered orally
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daratumumab
Description: Administered intravenously or subcutaneously
Study NCT06413498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carfilzomib
Description: Administered intravenously
Study NCT06072586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDTX-1535
Description: BDTX-1535 is an inhibitor of EGFR mutations
Study NCT06404827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Horseback riding simulator
Description: Horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation.
Study NCT06404827 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Physiotherapy and Rehabilitation
Description: Routine Physiotherapy and Rehabilitation within a spesific programme
Study NCT06801067 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SER-155
Description: SER-155 (Cultivated Multi-Strain Live Bacterial Therapeutic, Encapsulated) is an experimental designed ecology of 16 unique, human-commensal bacterial strains encapsulated for oral administration and will be provided by Seres as an investigational drug
Study NCT06404827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physiotherapy and Rehabilitation
Description: Routine Physiotherapy and Rehabilitation within a spesific programme
Study NCT05885555 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ianalumab
Description: Intravenous infusion, prepared from concentrate solution
Study NCT06480734 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: symptom-based scoring system (symptom-questionnaire, paper version)
Description: The patients are asked to complete a paper-based questionnaire (symptom-based scoring system, paper version) once a week during and up to 24 weeks following radiotherapy. The patients state and score symptoms potentially associated with pneumonitis, namely cough, shortness of breath and fever. Scoring points are assigned to severity of the symptoms, and sum scores are used to identify pneumonitis. During the radiotherapy course, patients complete the questionnaire prior to regular appointments with a physician. Following radiotherapy, they are contacted by phone (to minimize the number of hospital visits) once a week for completion of the questionnaire. In case of an increase of the total score when compared to baseline, patients receive a follow-up phone call after 3 days, are asked to come to the hospital as outpatients or are admitted to hospital.
Study NCT06801691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: Intervention group
Description: Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.
Study NCT06800326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Participants will have either an ultrasound or magnetic resonance imaging, depending on what scan they have had as part of their standard of care.
Study NCT06800326 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRE Scan
Description: Participants will have either an ultrasound or magnetic resonance imaging, depending on what scan they have had as part of their standard of care.
Study NCT04930016 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of life diagnosis and therapy during the completed RCT DIQOL
Description: Quality of life measurement, diagnosis, and tailored therapy (pain therapy, psychotherapy, social support, nutrition, stoma care, physiotherapy, fitness)
Study NCT06367608 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ExAblate Transcranial treatment
Description: The ExAblate Transcranial system will be used to destroy a small cluster of cells that may be causing the study participant's dystonia . The ExAblate uses ultrasound to heat a small spot in the brain called globus pallidus internus(GPi). Ultrasound passes through the skin and skull and into the brain to focus on this particular spot.
Study NCT04801459 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Direction procedure of gastrointestinal anastomosis in Roux-en-Y reconstruction
Description: In this study, intervention methods include two kind directions of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer. One is the isoperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was consistent. The other is the antiperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was opposite.
Study NCT05305508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Dobesilate
Description: The treatment (CaD, Calcium Dobesilate 500 mg) will be administered orally twice a day for 7 days.
Study NCT05305508 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mannitol
Description: The comparator (placebo, Mannitol 500 mg) will be administered orally twice a day for 7 days.
Study NCT05521906 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM)
Description: The intervention focuses on psycho-education (provision of accurate information about LGBTQIA2S+ people, education about the effects of alcohol), fostering positive identity development for LGBTQIA2S+ youth (e.g., fostering pride in identity, exposure to positive adult role models), teaching of alcohol use and sexual refusal skills, correction of inaccurate social norms about alcohol use and dating violence, teaching assertive communication skills, teaching emotion coping skills, mindfulness and grounding skills, and teaching bystander intervention skills related to dating/sexual violence and alcohol use..
Study NCT04150042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Intravenous melphalan (to be given in conjunction with the other listed drugs).
Study NCT04150042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BCNU
Description: Intravenous BCNU (to be given in conjunction with the other listed drugs).
Study NCT04150042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin B12B
Description: Intravenous vitamin B12b (to be given in conjunction with the other listed drugs).
Study NCT04150042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Intravenous vitamin C (to be given in conjunction with the other listed drugs).
Study NCT04150042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethanol
Description: Intravenous ethanol (to be given in conjunction with the other listed drugs).
Study NCT04150042 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Hematopoietic Stem Cells
Description: After each cycle of chemotherapy, participants will receive an autologous hematopoietic stem cell infusion.
Study NCT04801459 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Direction procedure of gastrointestinal anastomosis in Roux-en-Y reconstruction
Description: In this study, intervention methods include two kind directions of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer. One is the isoperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was consistent. The other is the antiperistaltic anastomosis, representing the peristalsis direction of remnant stomach and jejunal efferent loop was opposite.
Study NCT05758389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
Description: evaluate the efficacy and safety of immunotherapy combined with chemotherapy
Study NCT05055518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APL-102 Capsules
Description: Dose escalation: A total of seven dose levels (1mg, 2mg, 3mg, 5mg, 7mg, 9mg and 11mg) are planned.~Dose extension: After RP2D determined, the RP2D dose level will be extended to enroll 6-10 subjects to further evaluated the safety and antitumor activity of APL-102.
Study NCT06163989 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TheaLoz Duo Eyedrop
Description: TheaLoz Duo lubricating eyedrop contains 3.0% trehalose and 0.15% sodium hyaluronate as active ingredients and will be used by participants everyday to instill 1 drop, 4 times a day in both eyes.
Study NCT06163989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TheaLoz Duo Eyedrop
Description: TheaLoz Duo lubricating eyedrop contains 3.0% trehalose and 0.15% sodium hyaluronate as active ingredients and will be used by participants everyday to instill 1 drop, 4 times a day in both eyes.
Study NCT06801366 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Parent-recorded smartphone video clips
Description: Parents will record smartphone video clips of their child asleep, which will be scored by pediatric sleep physicians for presence of moderate-severe OSA. Children will then undergo clinically indicated polysomnography (PSG). Video clips will be evaluated for diagnostic accuracy, with PSG as the gold standard.
Study NCT06801457 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NBO
Description: NBO will be conducted with inhalation of 100% oxygen.
Study NCT06801457 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Best medical care
Study NCT06801730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan liposome combined with bevacizumab
Description: Irinotecan liposomes, 50mg/m2, d1, 90 min intravenously, Q2W; Bevacizumab 10mg/kg, d1, Q2W;
Study NCT06801548 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esthetic crown lengthening surgery
Description: Esthetic crown lengthening surgery using mock-up based guide
Study NCT06801548 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esthetic crown lengthening surgery using Digital guide
Description: 1- Int
Study NCT06797830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AllCore
Description: AllCore360° is a novel core-strengthening machine intervention designed to target trunk muscles through gravity by means of high-intensity constant velocity rotating exercise (allcore360.com).~AllCore360° is systematic, consistent and designed for use over time. The core is strengthened because a patient's core muscles are used in anterior, lateral, and posterior contractions sequentially during a single rotation (Palevo). The patient must resist gravity with the rotation as well as contract and fire isometrically to keep proper posture. Using proper posture, the patient must keep their back straight and neck neutral throughout the length of the intervention without relying on their lower body muscles at all (this is assisted by straps rendering the legs useless and by securing the pelvis in the chair).
Study NCT06801301 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: whole body vibration
Description: Standing in different static positions or exercising on a vibrating platform.The mechanical stimuli of vibration transmitted to the body and stimulate muscle spindles which activate the alpha motor neurons and initiates muscle contractions comparable to the ''tonic vibration reflex. The effect of WBV on the neuromuscular properties of skeletal muscles and spinal mechanisms is demonstrated by a decreased electromechanical delay.
Study NCT06801301 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Exercise
Description: Resistance training as a mode of exercise to promote several health benefits, including improvements in the muscle mass and strength of healthy adults.Resistance training, where muscles are required to contract against an opposing load, has been shown to be a beneficial form of rehabilitation in clinical populations prone to muscle wasting, providing stimuli to increase protein synthesis and muscle mass.
Study NCT06800872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidisciplinary metabolic rehabilitation
Description: Standard in-hospital protocol of multidisciplinary metabolic rehabilitation
Study NCT06800872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidisciplinary metabolic rehabilitation + training with WBVE
Description: Standard in-hospital protocol of multidisciplinary metabolic rehabilitation + 24 sessions (2 sessions per day) of 30 minutes each of training on a vibration platform (WBVE)
Study NCT06802068 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: whole salmon oil
Description: A minimally processed whole salmon oil
Study NCT06802068 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cod liver oil
Description: Standard, processed omega-3 cod liver oil
Study NCT06801158 — intervention group
Intervention type: DRUG
Intervention: use of anticancer drugs in monotherapy or in combination therapy
Description: ICSRs involving antineoplastic or immunomodulating agents were included.
Study NCT06801522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.1% xylometazoline nasal drops
Description: Xylometazoline is direct acting, non selective, adrenergic agonist binding with alpha 1\&2 receptors, used for vasoconstriction to decrease nasal bleeding.
Study NCT06801522 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adrenaline nasal pack
Description: Adrenaline is direct acting, non selective, adrenergic agonist binding with alpha and beta receptors both, used for vasoconstriction to decrease nasal bleeding.
Study NCT06800963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intravesical Recombinant Mycobacterium (rMBCG)
Description: 19.2e8 CFU (1 vial) rMBCG via a urinary catheter in the bladder (ie, intravesical administration)
Study NCT06800235 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computer-Assisted Simulation
Description: Nursing students in the experimental group were informed about computer-based simulation. They were also informed about the aspiration skill form and general competency scale.
Study NCT06800235 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control grup
Description: Nursing students in the control group were informed about the standard procedure/traditional method. They were also informed about the aspiration skill form and general competency scale.
Study NCT06800417 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous fixation by internal cemented screw (InnoFix®)
Description: Percutaneous fixation by internal cemented screw
Study NCT06801717 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: KTP Laser Therapy
Description: Participants will receive full face treatments with 532 nm KTP laser for 3 sessions at 8-12 weeks apart. Laser therapy will be conducted in person. Each laser treatment session will last up to 10 minutes.
Study NCT06801717 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Radiofrequency microneedling
Description: Participants will receive unilateral facial treatments with radiofrequency microneedling device for 3 sessions at 8-12 weeks apart. Radiofrequency microneedling will be conducted in person. Each treatment session will last up to 1 hour.
Study NCT06800846 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraosseous Morphine
Description: Participants received combinations of 0.5% bupivacaine 100 mg + 0.1% adrenaline 0.6 mg + Morphine 5mg + Ketorolac 30 mg (totally 22 ml) which divided by 12 ml inject into intramedullary canal before bone plug impaction to close the canal and 10 ml inject into metaphysis of tibia before cementation and implantation
Study NCT06800846 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Periarticular Injection
Description: Participants received combinations of 0.5% bupivacaine 100 mg + 0.1% adrenaline 0.6 mg + Morphine 5mg + Ketorolac 30 mg and mix with normal saline solution for totally 75 ml which divided by 25 ml inject into medial gutter and 25 ml inject into lateral gutter before cementation and implantation. And the last 25 ml of multimodal analgesic drugs were injected into quadriceps.
Study NCT06800612 — intervention group
Intervention type: DRUG
Intervention: Oncologic drugs administered for treatment of breast cancer
Description: Data on oncologic drugs administered for treatment of breast cancer will be recorded
Study NCT06800612 — intervention group
Intervention type: DRUG
Intervention: Oncologic drug administered for treatment of gynecologic cancer
Description: Data on oncologic drugs administered for treatment of gynecologic cancer will be recorded
Study NCT05190172 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation therapy
Description: Radiation therapy either with protons or photons
Study NCT05190172 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Radiation therapy either with protons or photons
Study NCT06801769 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: C-peptide
Description: Measurement of C-peptide at 5 time points during a standard oral glucose tolerance test (OGTT).
Study NCT06799572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: massage
Description: Hands will be washed with hand soap and rubbed with disinfectant before the procedure.~* The head of the bed is raised by 30°-45° in the incubator.~* The baby is placed face down.~* Vaseline is applied to the hands.~* The 15 minute session will consist of three 5 minute phases. Phase 1 will be tactile stimulation phase, Phase 2 will be kinesthetic stimulation and Phase 3 will be I Love You technique.~* In the tactile stimulation phase, the infant is turned to the prone position and a stroking motion (12 strokes in approximately 5 seconds) will be applied with moderate pressure in 1-minute intervals, from the top of the head to the neck and back to the top of the head, from the neck to the shoulder, from the neck to the shoulder, from the upper back to the waist and back to the upper back, from the thigh to the foot and both legs, from the shoulder to the hand and from both arms to the shoulder.~* In the kinesthetic stimulation phase, the infant is placed in the supine position and eac